Home/Case Studies/Case Study 3
Research Case Study 3

PEMF Therapy and Knee Strength in Osteoarthritis: The 2026 Lau Trial

A 2026 placebo-controlled trial studied an eight-week course of PEMF in people with refractory mild-to-moderate knee osteoarthritis and reported a later improvement in knee extension strength.

2026Double-blind, randomised, placebo-controlled trialPMID: 41588476
Knee Strength and OA PEMF research case study
Illustrative research thumbnail; it does not depict an individual study participant.

The Evidence in One Minute

Research type: Double-blind, randomised, placebo-controlled trial

Main finding: At six months, the PEMF group showed a statistically significant improvement in knee extension peak torque compared with sham. The paper reported a 72% increase from baseline versus 25% in the sham group.

Essential caution: This paper did not test the OlyLife P90 Plus.

The Research

What Did the Study Examine?

Original Research Source

AuthorsLau et al.
Published2026
Study typeDouble-blind, randomised, placebo-controlled trial
JournalJournal of Cachexia, Sarcopenia and Muscle
DatabasePubMed, PMID 41588476

Open PubMed record

A 2026 placebo-controlled trial studied an eight-week course of PEMF in people with refractory mild-to-moderate knee osteoarthritis and reported a later improvement in knee extension strength.

At six months, the PEMF group showed a statistically significant improvement in knee extension peak torque compared with sham. The paper reported a 72% increase from baseline versus 25% in the sham group.

Interpretation

What Does This Research Mean?

The most defensible conclusion is that the studied course may have helped knee extensor strength in this particular group. Strength, pain, cartilage and daily function are separate outcomes.

Yes

What it supports

PEMF deserves consideration within the specific research context.

No

What it does not prove

Not every PEMF device or programme produces the same result.

Care

How to use it

Compare the exact research device, protocol and intended use.

Study Limits

Important Limitations

  • No significant between-group differences were found for lean mass, cartilage thickness, joint-space width, walk time, chair stands or WOMAC.
  • A strength outcome does not automatically mean less pain or restored cartilage.
  • The result came from a specific research device and protocol.
  • The trial does not establish equivalent results for a home consumer device.
Product Context

How Does This Relate to the OlyLife P90 Plus?

The Lau trial cannot be used to prescribe a P90 Plus frequency, intensity or eight-week programme. Follow the exact manual and maintain appropriate knee osteoarthritis care.

Related consumer wellness product

OlyLife P90 Plus Tera Machine

The P90 Plus is marketed as a premium home wellness machine with PEMF-focused features, TeraHertz positioning, temperature control and a touch interface. It is not automatically equivalent to a device used in research.

View the P90 Plus product page

Research-to-product warning: Do not say that the P90 Plus reproduces the exact study protocol unless waveform, field strength, frequency, applicator, placement and schedule are verified.
Practical Next Steps

How to Use This Evidence Responsibly

1

Read the source

Use the original paper rather than relying only on a marketing summary.

2

Confirm the diagnosis

Similar symptoms can have different causes and treatments.

3

Compare devices

Check exact output and intended use, not only a frequency label.

4

Track outcomes

Record benefits or adverse effects without changing prescribed care.

Internal Resources

Continue Your PEMF Research

PEMF Therapy Benefits

Continue with this related PEMF guide for more context.

Read guide

Choose the Right OlyLife Device

Continue with this related PEMF guide for more context.

Read guide

OlyLife P90 Plus Review

Continue with this related PEMF guide for more context.

Read guide

FAQs

Questions About This Case Study

Did the study show improved knee pain?

Its main between-group finding was knee extension strength; WOMAC outcomes did not differ significantly.

Did PEMF rebuild cartilage?

No significant between-group difference was found for cartilage thickness or joint-space width.

Can this become a P90 Plus protocol?

No. The study used a specific research device and protocol.

Medical and research disclaimer: This page summarises research for education. It does not diagnose, prescribe treatment or prove that a consumer device will reproduce a study result.

Explore the Complete Research Library

Review all six evidence summaries, then continue to the safety, technology and device guides.

Scroll to Top